These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30467431)

  • 1. Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) and its soluble in the plasma form (sTREM-1) as a diagnostic biomarker in neonatal sepsis.
    Patoulias D; Kalogirou MS; Patoulias I
    Folia Med Cracov; 2018; 58(2):15-19. PubMed ID: 30467431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
    Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
    Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TREM-1 is not a useful biomarker in the diagnosis of early-onset neonatal sepsis.
    Cayir Koc TN; Kahvecioglu D; Cetinkaya AK; Oktem A; Tas M; Dogan H; Senes M
    Future Microbiol; 2024; 19(17):1489-1496. PubMed ID: 39382003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis.
    Tunç T; Polat A; Özdemir R; Kiliçaslan B; Can E; Çelik HT; Arsan S; Kader Ş; Erol S; Uslu S; Özdemir ÖMA; ; Özcan B; Hanta D; Dilli D; Narter F; Gültekin N; Güzoğlu N; Aydemir Ö
    J Neonatal Perinatal Med; 2020; 13(1):47-54. PubMed ID: 31594258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis?
    Lemarié J; Gibot S
    Crit Care Clin; 2020 Jan; 36(1):41-54. PubMed ID: 31733681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.
    Cao C; Gu J; Zhang J
    Front Med; 2017 Jun; 11(2):169-177. PubMed ID: 28425045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.
    Jedynak M; Siemiatkowski A; Mroczko B; Groblewska M; Milewski R; Szmitkowski M
    Arch Immunol Ther Exp (Warsz); 2018 Aug; 66(4):299-306. PubMed ID: 29282483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis.
    Chang W; Peng F; Meng SS; Xu JY; Yang Y
    BMC Immunol; 2020 Jan; 21(1):2. PubMed ID: 31931717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis.
    Bellos I; Fitrou G; Daskalakis G; Thomakos N; Papantoniou N; Pergialiotis V
    Inflamm Res; 2018 Jul; 67(7):571-578. PubMed ID: 29644420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of urine soluble triggering receptor expressed on myeloid cells (sTREM-1) for late-onset neonatal sepsis in infected preterm neonates.
    Alkan Ozdemir S; Ozer EA; Ilhan O; Sutcuoglu S; Tatlı M
    J Int Med Res; 2018 Apr; 46(4):1606-1616. PubMed ID: 29480083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic predictive values of triggering receptor expressed on myeloid cell-1 expression in neonatal sepsis: A meta-analysis and systematic review.
    Chang C; Gao Q; Deng G; Luo K; Zhu H
    Front Pediatr; 2022; 10():929665. PubMed ID: 35935355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
    Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
    BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis.
    Su L; Liu C; Li C; Jiang Z; Xiao K; Zhang X; Li M; Yan P; Feng D; Xie L
    Inflammation; 2012 Dec; 35(6):1833-43. PubMed ID: 22798017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.
    Edel Y; Kliminski V; Pokroy-Shapira E; Oren S; Dortort Lazar A; Pri-Paz Basson Y; Egbaria M; Molad Y
    Arthritis Res Ther; 2019 Jan; 21(1):10. PubMed ID: 30616644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
    Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
    Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TREM-1 in pulmonary tuberculosis patients- analysis of serum soluble TREM-1 levels.
    Feng JY; Su WJ; Pan SW; Yeh YC; Lin YY; Chen NJ
    Sci Rep; 2018 May; 8(1):8223. PubMed ID: 29844416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble triggering receptor expressed on myeloid cells-1 as a serum biomarker of early neurologic deterioration and prognosis in acute supratentorial intracerebral hemorrhage.
    Gu Y; Deng X; Liang C; Chen Y; Lei H; Zhang Q
    Clin Chim Acta; 2021 Dec; 523():290-296. PubMed ID: 34655609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in neonatal sepsis.
    Doughty C; O'Driscoll DN; Smith S; O'Currain E; Grant T; O'Hare FM; Culliton M; Watson RWG; O'Neill A; Molloy EJ
    J Matern Fetal Neonatal Med; 2022 Jul; 35(13):2485-2492. PubMed ID: 32674630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
    Du C; Peng L; Kou G; Wang P; Lu L; Li Y
    Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
    Liu CJ; Tsai CY; Chiang SH; Tang SJ; Chen NJ; Mak TW; Sun GH; Sun KH
    J Autoimmun; 2017 Mar; 78():92-100. PubMed ID: 28089248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.